Related Experiment Video
Updated: Jul 19, 2026

07:34
Minimally-invasive Technique for Injection into Rat Optic Nerve
Published on: May 19, 2015
10.1K
Visual Neurorestoration: An Expert Review of Current Strategies for Restoring Vision in Humans
Jonathon Cavaleri1, Michelle Lin1, Kevin Wu1
1Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 900033, USA.
Brain Sciences
|November 27, 2025
Summary
Restoring vision loss involves advanced therapies like stem cells, gene editing, and neuroprosthetics. Further research and multidisciplinary collaboration are crucial for significant visual restoration in challenging conditions.
Area of Science:
- Neuroscience
- Ophthalmology
- Biomedical Engineering
Background:
- Visual impairment affects nearly half a billion people globally.
- Current treatments improve some eye conditions but have limited strategies for retinopathies, optic nerve damage, and visual pathway disorders.
- The visual system's complexity necessitates innovative approaches beyond traditional methods.
Purpose of the Study:
- To review current literature on visual neurorestoration strategies.
- To explore advancements in cellular therapeutics, genetic therapies, optogenetics, neuroprosthetics, neuromodulation, and whole-eye transplantation.
- To highlight the need for multidisciplinary efforts in restoring functional vision.
Main Methods:
- Review of scientific literature on visual neurorestoration.
- Analysis of emerging therapeutic modalities including cellular replacement, gene therapy, optogenetics, and neuroprosthetics.
- Examination of recent developments in whole-eye transplantation and non-invasive neuromodulation.
Main Results:
- Novel treatments like stem cell therapy, gene editing, and optogenetics show promise for retinal damage.
- Retinal and central nervous system neuroprosthetics are in early development stages.
- Whole-eye transplantation demonstrated feasibility, with future research focusing on axonal regeneration.
Conclusions:
- Current visual neurorestoration methods offer modest improvements, necessitating further development.
- Integrating cellular therapies, genetic engineering, transplantation, and neuromodulation is key to restoring functional vision.
- A collaborative, multidisciplinary approach is essential for addressing complex vision loss pathologies.
Keywords:
blindnesseye transplantgenetic engineeringneuromodulationoptogeneticsstem cell therapyvisual impairmentMore Related Videos
Related Concept Videos
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

